Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 19

1.

CD8+ T cell cross-priming via transfer of proteasome substrates.

Norbury CC, Basta S, Donohue KB, Tscharke DC, Princiotta MF, Berglund P, Gibbs J, Bennink JR, Yewdell JW.

Science. 2004 May 28;304(5675):1318-21.

2.

Heat shock proteins in antigen trafficking--implications on antigen presentation to T cells.

Udono H, Ichiyanagi T, Mizukami S, Imai T.

Int J Hyperthermia. 2009 Dec;25(8):617-25. doi: 10.3109/02656730902902183. Review.

PMID:
19551545
3.

Generating MHC class I ligands from viral gene products.

Yewdell J, Antón LC, Bacik I, Schubert U, Snyder HL, Bennink JR.

Immunol Rev. 1999 Dec;172:97-108. Review.

PMID:
10631940
4.
5.

The role of the ubiquitin-proteasome pathway in MHC class I antigen processing: implications for vaccine design.

Sijts A, Zaiss D, Kloetzel PM.

Curr Mol Med. 2001 Dec;1(6):665-76. Review.

PMID:
11899255
6.

Lactacystin, proteasome function, and cell fate.

Fenteany G, Schreiber SL.

J Biol Chem. 1998 Apr 10;273(15):8545-8. Review. No abstract available.

7.

Priming of T cells by exogenous antigen cross-presented on MHC class I molecules.

Shen L, Rock KL.

Curr Opin Immunol. 2006 Feb;18(1):85-91. Epub 2005 Dec 2. Review.

PMID:
16326087
8.

Proteasome inhibitors and antigen presentation.

Bogyo M, Gaczynska M, Ploegh HL.

Biopolymers. 1997;43(4):269-80. Review.

PMID:
9316392
9.

Pathways for antigen cross presentation.

Guermonprez P, Amigorena S.

Springer Semin Immunopathol. 2005 Jan;26(3):257-71. Epub 2004 Dec 3. Review.

PMID:
15592842
10.

[Intracellular processing of viral and tumor antigens by proteasomes].

Groettrup M, Schmidtke G.

Schweiz Med Wochenschr. 1999 Nov 6;129(44):1660-5. Review. German.

PMID:
10588025
11.

Antigen processing by the proteasome.

Kloetzel PM.

Nat Rev Mol Cell Biol. 2001 Mar;2(3):179-87. Review.

PMID:
11265247
12.

[Advance in the study on the proteasome activator PA28].

Murata S, Chiba T.

Tanpakushitsu Kakusan Koso. 2000 Aug;45(11):1832-40. Review. Japanese. No abstract available.

PMID:
10936967
13.

Proteasome inhibitors.

Reboud-Ravaux M.

Prog Mol Subcell Biol. 2002;29:110-25. Review. No abstract available.

PMID:
11908069
14.

Functions of the proteasome in antigen presentation.

Goldberg AL, Gaczynska M, Grant E, Michalek M, Rock KL.

Cold Spring Harb Symp Quant Biol. 1995;60:479-90. Review. No abstract available.

PMID:
8824421
15.

Designing CD8+ T cell vaccines: it's not rocket science (yet).

Yewdell JW.

Curr Opin Immunol. 2010 Jun;22(3):402-10. doi: 10.1016/j.coi.2010.04.002. Epub 2010 May 4. Review.

16.

Role of N-linked glycans, chaperone interactions and proteasomes in the intracellular targeting of apolipoprotein(a).

Wang J, White AL.

Biochem Soc Trans. 1999 Aug;27(4):453-8. Review. No abstract available.

PMID:
10917619
17.

Peptide antigen production by the proteasome: complexity provides efficiency.

Groettrup M, Soza A, Kuckelkorn U, Kloetzel PM.

Immunol Today. 1996 Sep;17(9):429-35. Review. No abstract available.

PMID:
8854562
18.

A whodunit: an appointment with death.

Giodini A, Albert ML.

Curr Opin Immunol. 2010 Feb;22(1):94-108. doi: 10.1016/j.coi.2010.01.023. Epub 2010 Feb 18. Review.

PMID:
20171862
19.

Recent approaches to the pathogenesis of minimal-change nephrotic syndrome.

Grimbert P, Audard V, Remy P, Lang P, Sahali D.

Nephrol Dial Transplant. 2003 Feb;18(2):245-8. Review. No abstract available.

PMID:
12543875

Supplemental Content

Support Center